Avacta Appoints CFO
This article was originally published in Scrip
Avacta Group Plc. has appointed Tony Gardiner group chief financial officer (CFO) – effective Jan. 4, 2016. Gardiner joins Avacta from architecture and building consultancy practice AHR, where he was finance director. Previously he was CFO of AIM listed Fusion IP Plc., an IP commercialization company and he also held senior finance roles within Eversheds LLP, KCOM Group Plc. Eldon Electric Ltd. and Hickson International Plc.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.